HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.20, $0.02 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $203.3 million versus the consensus estimate of $200.1 million.

GUIDANCE:

HealthEquity sees FY2023 EPS of $1.21-$1.30, versus the consensus of $1.41. HealthEquity sees FY2022 revenue of $820-830 million, versus the consensus of $817.4 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.